alexa The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report

 The main objective of this clinical case presentation is to attract attention about the risk of therapy with interferon and ribavirin.The risk of therapy with interferon and Ribavarin has been reported, such as: dominated by fatigue, influenza-like symptoms, hematologic abnormalities, and neuropsychiatric symptoms [1,2], but the risk of breast carcinoma of therapy with interferon and Ribavarin has not been seen

Citation: Stoicescu M (2013) The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report. J Develop Drugs. 2:102. doi: 10.4172/2329-6631.1000102

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords